|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
LU86084A1
(fr)
|
1985-09-20 |
1987-04-02 |
Faco Sa |
Apparei de massage electrique
|
|
US5102417A
(en)
|
1985-11-07 |
1992-04-07 |
Expandable Grafts Partnership |
Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
|
|
US4800882A
(en)
|
1987-03-13 |
1989-01-31 |
Cook Incorporated |
Endovascular stent and delivery system
|
|
US4886062A
(en)
|
1987-10-19 |
1989-12-12 |
Medtronic, Inc. |
Intravascular radially expandable stent and method of implant
|
|
WO1990013332A1
(en)
|
1989-05-11 |
1990-11-15 |
Cedars-Sinai Medical Center |
Stent with sustained drug delivery
|
|
DE69110787T2
(de)
|
1990-02-28 |
1996-04-04 |
Medtronic, Inc., Minneapolis, Minn. |
Intraluminale prothese mit wirkstoffeluierung.
|
|
US5419760A
(en)
|
1993-01-08 |
1995-05-30 |
Pdt Systems, Inc. |
Medicament dispensing stent for prevention of restenosis of a blood vessel
|
|
US5429634A
(en)
|
1993-09-09 |
1995-07-04 |
Pdt Systems |
Biogenic implant for drug delivery and method
|
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
|
US5833651A
(en)
|
1996-11-08 |
1998-11-10 |
Medtronic, Inc. |
Therapeutic intraluminal stents
|
|
US6166050A
(en)
*
|
1998-12-14 |
2000-12-26 |
American Home Products Corporation |
3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
AR033803A1
(es)
|
2000-03-01 |
2004-01-07 |
Smithkline Beecham Corp |
Compuestos de dianilino escuarano, composiciones farmaceuticas que los comprenden, y el uso de los mismos en la fabricacion de medicamentos para tratar enfermedades mediadas por quimioquinas
|
|
CN1454204A
(zh)
|
2000-05-30 |
2003-11-05 |
史密丝克莱恩比彻姆公司 |
Il－8受体拮抗剂
|
|
JP2004520412A
(ja)
|
2001-01-16 |
2004-07-08 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ−８受容体アンタゴニスト
|
|
DE60216229T2
(de)
|
2001-01-16 |
2007-10-04 |
Smithkline Beecham Corp. |
Il-8-rezeptorantagonisten
|
|
WO2002076926A1
(en)
|
2001-02-02 |
2002-10-03 |
Schering Corporation |
3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
|
|
US20030204085A1
(en)
|
2001-02-02 |
2003-10-30 |
Taveras Arthur G. |
3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
|
|
US7132445B2
(en)
|
2001-04-16 |
2006-11-07 |
Schering Corporation |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
|
|
US20040097547A1
(en)
|
2001-04-16 |
2004-05-20 |
Taveras Arthur G. |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
|
|
US20040106794A1
(en)
|
2001-04-16 |
2004-06-03 |
Schering Corporation |
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
|
|
CN1289471C
(zh)
|
2001-04-16 |
2006-12-13 |
先灵公司 |
作为cxc－趋化因子受体配体的3,4－二取代的环丁烯－1,2－二酮
|
|
WO2003080053A1
(en)
|
2002-03-18 |
2003-10-02 |
Schering Corporation |
Combination treatments for chemokine-mediated diseases
|
|
US6770729B2
(en)
|
2002-09-30 |
2004-08-03 |
Medtronic Minimed, Inc. |
Polymer compositions containing bioactive agents and methods for their use
|
|
DE602004025458D1
(de)
|
2003-04-18 |
2010-03-25 |
Schering Corp |
SYNTHESE VON 2-HYDROXY-N,N-DIMETHYL-3-ii2-i1(R)-(5-METHYL-2-FURANYL)PROPYL AMINO -3,4-DIOXO-1-CYCLOBUTEN-1-YL AMINO BENZAMID
|
|
RU2388756C2
(ru)
|
2004-01-30 |
2010-05-10 |
Шеринг Корпорейшн |
Кристаллические полиморфные формы лиганда схс-хемокинового рецептора
|
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
|
GB0419481D0
(en)
|
2004-09-02 |
2004-10-06 |
Cancer Rec Tech Ltd |
Isoindolin-1-one derivatives
|
|
DE102005035742A1
(de)
|
2005-07-29 |
2007-02-01 |
Merck Patent Gmbh |
Quadratsäurederivate II
|
|
WO2008005570A1
(en)
|
2006-07-07 |
2008-01-10 |
Schering Corporation |
3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
|
|
JP2010520293A
(ja)
|
2007-03-07 |
2010-06-10 |
アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド |
複素環式部分を含有するメタロプロテアーゼ阻害剤
|
|
EP2155670B1
(en)
|
2007-06-06 |
2012-04-18 |
Novartis AG |
Anti -inflammatory substituted cyclobutenedione compounds
|
|
CN101932553A
(zh)
|
2007-07-03 |
2010-12-29 |
先灵公司 |
合成1,2-取代的3,4-二氧代-1-环丁烯化合物的方法和中间体
|
|
JP2010532357A
(ja)
|
2007-07-05 |
2010-10-07 |
シェーリング コーポレイション |
１，２−置換３，４−ジオキソ−１−シクロブテン化合物における制御された結晶サイズのための方法
|
|
WO2009012375A2
(en)
|
2007-07-19 |
2009-01-22 |
Wyeth |
Squarate kinase inhibitors
|
|
EP2215074B1
(en)
|
2007-09-27 |
2014-02-19 |
The United States of America, as Represented by the Secretary, Department of Health and Human Services |
Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
|
|
EP2252327A2
(en)
|
2007-12-04 |
2010-11-24 |
Schering Corporation |
Methods of treating copd
|
|
WO2009156421A1
(en)
|
2008-06-24 |
2009-12-30 |
Topotarget A/S |
Squaric acid derivatives as inhibitors of the nicotinamide
|
|
UA103198C2
(en)
|
2008-08-04 |
2013-09-25 |
Новартис Аг |
Squaramide derivatives as cxcr2 antagonists
|
|
AU2009303441A1
(en)
|
2008-10-16 |
2010-04-22 |
Schering Corporation |
Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
|
|
WO2010063802A1
(en)
|
2008-12-05 |
2010-06-10 |
Novartis Ag |
3, 4-di-substituted cyclobutene- 1, 2 -diones as cxcr2 receptor antagonists
|
|
WO2010091543A1
(en)
|
2009-02-10 |
2010-08-19 |
Merck Sharp & Dohme Corp. |
Novel hydrazino-cyclobut-3-ene-1, 2-dione derivatives as cxcr2 antagonists
|
|
WO2010131145A1
(en)
|
2009-05-12 |
2010-11-18 |
Pfizer Limited |
Cyclobutenedione derivatives
|
|
FR2961695B1
(fr)
|
2010-06-29 |
2012-07-06 |
Galderma Res & Dev |
Utilisation de composes dans le traitement ou la prevention de troubles cutanes
|
|
US8648070B2
(en)
|
2010-12-17 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
|
|
US8648118B2
(en)
|
2010-12-17 |
2014-02-11 |
Boehringer Ingelheim International Gmbh |
Bicyclic ring system substituted amide functionalised phenols as medicaments
|
|
ES2655942T3
(es)
|
2011-09-02 |
2018-02-22 |
Novartis Ag |
Sal de colina de un compuesto anti-inflamatorio de ciclobutenodiona sustituida
|
|
FR2981934B1
(fr)
*
|
2011-10-28 |
2013-12-20 |
Galderma Res & Dev |
Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
|
|
FR2981936B1
(fr)
|
2011-10-28 |
2013-12-20 |
Galderma Res & Dev |
Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
|
|
FR2981935B1
(fr)
|
2011-10-28 |
2015-08-07 |
Galderma Res & Dev |
Nouveaux composes di-substitues de la diamino-3,4-cyclobutene-3-dione-1,2 utiles dans le traitement de pathologies mediees par des chimiokines.
|
|
SI3536710T1
(sl)
*
|
2011-11-16 |
2026-04-30 |
Boehringer Ingelheim International Gmbh |
Protitelesa proti IL-36R
|
|
CA2873984A1
(en)
|
2012-05-23 |
2013-11-28 |
Stemergie Biotechnology Sa |
Inhibitors of the activity of complex (iii) of the mitochondrial electron transport chain and use thereof
|
|
WO2015170430A1
(ja)
*
|
2014-05-08 |
2015-11-12 |
学校法人慶應義塾 |
大動脈解離後の炎症性障害抑制剤
|
|
EP3220951A1
(en)
|
2014-11-17 |
2017-09-27 |
MedImmune Limited |
Therapeutic combinations and methods for treating neoplasia
|
|
TWI724056B
(zh)
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Ｃｘｃｒ２抑制劑
|
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
|
EP3737366B1
(en)
|
2018-01-08 |
2026-02-25 |
ChemoCentryx, Inc. |
Methods of treating generalized pustular psoriasis with an antagonist of ccr6 or cxcr2
|